Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 23
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00016874 | 3-AP Plus Cisplatin and Paclitaxel in Treating Patients With Advanced or Metastatic Cancer | ||
| NCT00282022 | VNP40101M in Treating Patients With Relapsed or Refractory Locally Advanced or Metastatic Small Cell Lung Cancer | ||
| NCT00049686 | VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome | ||
| NCT00516282 | VNP40101M and Temozolomide in Treating Patients With Progressive or Relapsed Malignant Glioma | ||
| NCT00354276 | VNP40101M Followed by Cytarabine in Treating Older Patients With Acute Myeloid Leukemia | ||
| NCT00025129 | VNP40101M in Treating Patients With Advanced Solid Tumors or Lymphomas | ||
| NCT00004216 | VNP20009 in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Therapy | ||
| NCT00004213 | 3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone in Treating Patients With Solid Tumors | ||
| NCT00655395 | Treatment of Elderly Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic (MD) Syndrome With Laromustine and Infusional Cytarabine | ||
| NCT00098436 | Temozolomide and VNP40101M in Treating Patients With Relapsed or Refractory Leukemias | ||
| NCT00006218 | 3-AP in Treating Patients With Advanced Cancer | ||
| NCT00521859 | Cloretazine (VNP40101M) With Hematopoietic Cell Transplantation for Hematologic Malignancies | ||
| NCT00049699 | VNP40101M in Treating Patients With Advanced or Metastatic Cancer | ||
| NCT00024323 | Combination Chemotherapy in Treating Patients With Advanced Cancer | ||
| NCT00070538 | VNP40101M and Cytarabine in Treating Patients With Hematologic Malignancies | ||
| NCT00054015 | 3-AP in Treating Patients With Advanced Prostate Cancer | ||
| NCT00064064 | 3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung Cancer | ||
| NCT00064090 | 3-AP and Cytarabine in Treating Patients With Hematologic Cancer | ||
| NCT00064051 | 3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer | ||
| NCT00083187 | VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia | ||
| NCT00304005 | VNP40101M in Treating Patients With Richter Syndrome or Refractory or Relapsed Chronic Lymphocytic Leukemia or Other Lymphoproliferative Disorders | ||
| NCT00112554 | Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia | ||
| NCT00006254 | VNP20009 in Treating Patients With Advanced Solid Tumors |
